GHDX

Genomic Health Inc
63.44
0.00 (0.00%)

Genomic Health Inc. (GHDX) Fundamentals

Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer. Genomic offers the tissue-based invasive breast, DCIS, prostate, and colon Oncotype DX tests as clinical laboratory services. The company operates in one business segment, which primarily focuses on the development and global commercialization of genomic-based clinical laboratory services. Genomic derives most of its revenue from the United States.
SHARE INFORMATION
Market Cap$ 2,384,557,217
Shares Outstanding37,587,598
Float23,668,864
Percent Float62.97%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 387,315,000
Latest Fiscal EPS$ 0.67
Latest Fiscal Date2018-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions494
Institutional Holdings Date2019-10-31
Institutional Bought Previous 3 Months4,247,953
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months4,252,530
Insider Holdings Date2019-10-31
Insider Bought Previous 3 Months22
Insider Holdings Percent5.5
Insider Sold Previous 3 Months-
Insider Shares Owned2,056,671
TRADING INFO
52 Week High$ 86.70
52 Week Low$ 50.77
52 Week High Change$ -12.79
21 Day Moving Average$ 63.44
21 Day Extended Moving Average$ 63.8671
50 Day Moving Average$ 65.8576
50 Day Extended Moving Average$ 65.385
200 Day Moving Average$ 65.6186
200 Day Extended Moving Average$ 65.5525
10 Day Average Volume-
20 Day Average Volume-
30 Day Average Volume560,768
50 Day Average Volume471,656
Alpha0.011313
Beta0.8820
Standard Deviation0.118448
R20.066923
7 Day Price Change$ 0.00
7 Day Percent Change0.0%
21 Day Price Change$ 0.00
21 Day Percent Change0.0%
30 Day Price Change$ 0.00
30 Day Percent Change0.0%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ -4.38
Quarter to Date Percent Change-6.46%
180 Day Price Change$ 11.05
180 Day Percent Change21.09%
200 Day Price Change$ 9.37
200 Day Percent Change17.33%
Year to Date Price Change$ -0.97001
Year to Date Percent Change-1.51%

Genomic Health Inc. (GHDX) Key Ratios

PROFITABILITY
EBIT Margin12.6%
EBITDA Margin15.5%
Pre-Tax Profit Margin-3.7%
Profit Margin Count13.13%
Gross Margin84.4%
Profit Margin TOT13.13%
INCOME STATEMENTS
Revenue$ 431,011,000
Revenue Per Share$ 11.4668
Revenue (3 Years)$ 8.87
Revenue (5 Years)$ 8.87
FINANCIAL STRENGTH
Price to Tangible Book6.80
Total Debt To Equity0.20
Int Coverage0.00
Current Ratio6.00
Leverage Ratio1.30
Quick Ratio5.70
Long Term Debt To Capital0.13
VALUATION MEASURES
PE Ratio43.20
Enterprise Value$ 2,164,438,217
Price to Sales5.5325
Price to Free Cash33.00
PE High Last 5 Years0.00
Price To Book6.80
Price To Cash Flow26.90
PE Low Last 5 Years0.00
Price to Tangible Book6.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.70
Invoice Turnover0.00
Assets Turnover0.60
Return Assets14.88
Return on Equity19.01
Return on Capital15.04

Genomic Health Inc. (GHDX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOKimberly J. Popovits
Emplyoees829
Last AuditUE
CIK0001131324
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICSMedical Laboratories(621511)
CONTACT INFO
Address301 Penobscot Drive
Redwood City, CA 94063
Websitehttp://www.genomichealth.com
Facsimile-
Telephone+1 650 556-9300
Emailinvestors@genomichealth.com


Your Recent History
NASDAQ
GHDX
Genomic He..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.